Investing.com - Boston Scientific (NYSE:BSX) reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Boston Scientific announced earnings per share of $0.39 on revenue of $3.03B. Analysts polled by Investing.com anticipated EPS of $0.3857 on revenue of $2.96B.
Boston Scientific shares are up 0.28% from the beginning of the year and are trading at $42.60 , down-from-52-week-high.They are outperforming the S&P 500 which is down 12.4% from the start of the year.
Boston Scientific follows other major Healthcare sector earnings this month
Boston Scientific's report follows an earnings beat by J&J on Tuesday, April 19, 2022, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on Thursday, April 14, 2022 with first quarter EPS of $5.49 on revenue of $80.15B, compared to forecast for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar